Log in
Enquire now
Translation-X

Translation-X

Developer of novel therapeutics for autism spectrum disorders.

OverviewStructured DataIssuesContributors

Contents

trx-therapeutics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Biotechnology
Biotechnology
Health technology
Health technology
Location
Basel
Basel
Switzerland
Switzerland
CEO
‌
Özgür Genç
Founder
‌
Özgür Genç
Number of Employees (Ranges)
1 – 10
Email Address
ozgur.genc@unibas.ch
Investors
Venture Kick
Venture Kick
Founded Date
2022
Total Funding Amount (USD)
177,000
Latest Funding Round Date
October 2, 2024
Latest Funding Type
Pre-Seed
Pre-Seed

Other attributes

Latest Funding Round Amount (USD)
177,000
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Translation-X

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.